Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Lead sponsor
- UMC Utrecht
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- April 11, 2016
- Completion date
- February 29, 2028
- Enrollment
- 20,000 (estimated)
- Sites
- 408
Conditions
As the registry lists them; a condition with its own page is linked.
community-acquired pneumonia, influenza, covid-19